GlycoRegImmune partners with RxMD to develop new treatments using GlycoRegImmune's natural killer (NK) T cell targeted technologies

GlycoRegImmune Inc.

U.S. / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

RxMD Inc.

India / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced